ArticleWorld journal of experimental medicine2025
Effect of propolis and honey in hyperglycemia-induced kidney and liver injuries, proteinuria, and oxidant and antioxidant parameters.
Article in World journal of experimental medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPropolis and honey are known for their antioxidant, hypoglycemic, and antiproteinuric effects.
aimTo explore the effect of propolis, and honey, against D-glucose-induced hyperglycemia, acute kidney injury (AKI), liver injury, dyslipidemia, and changes in the oxidants and antioxidants in renal, hepatic, and pancreatic tissues.
methodsThe chemical analysis and antioxidant content of propolis and honey and their effect on alpha-amylase and alpha-glucosidase activity were studied. The study included five groups of male rats; four groups (2, 3, 4 and 5) were treated with D-glucose, and one group was untreated, group 1. In addition to D-glucose, groups 3, 4, and 5 were treated with propolis, honey, and their combination, respectively. Blood glucose levels, liver and renal function tests, urine protein and electrolytes, oxidant and antioxidant parameters, and histopathological changes in hepatic, renal, and pancreatic tissues were examined.
resultsPropolis contains a higher level of total protein and exhibits a higher antioxidant activity. Honey has a higher alpha-amylase and glucosidase inhibitory activity than propolis. D-glucose caused a significant elevation of blood glucose, insulin, homeostasis model assessment, blood urea, creatinine, lipid parameters, liver enzymes, and urine protein levels. It significantly increases malondialdehyde and decreases antioxidant parameters in pancreatic, hepatic, and renal tissues. D-glucose caused histopathological changes in hepatic, renal, and pancreatic tissues; these changes were significantly ameliorated by honey and propolis.
conclusionPropolis, honey, or their combination treated hyperglycemia, AKI, proteinuria, liver injury, and dyslipidemia induced by D-glucose, most likely, through their antioxidant activity and alpha-amylase and alpha-glucosidase inhibitory activity. This will pave the way for testing this natural combination in the prevention of diabetic complications, as a complement to basic therapies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.